Clinical trial
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in…
NCT00004128 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Unknown status
Key facts
| NCT number | NCT00004128 |
|---|---|
| Title | Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia |
| Official title | The Value of High Dose Versus Standard Dose ARA-C During Induction and of IL-2 After Intensive Consolidation/Autologous Stem Cell Transplantation in Patients (Age 15-60 Years) With Acute Myelogenous Leukemia. A Randomized Phase II Trial of the EORTC and the GIMEMA-ALWP |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Collaborators | Gruppo Italiano Malattie EMatologiche dell'Adulto |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | aldesleukin, filgrastim, busulfan, cyclophosphamide, cytarabine, daunorubicin hydrochloride, etoposide, autologous bone marrow transplantation, peripheral blood stem cell transplantation, radiation therapy |
| Enrollment | 2,000 |
| Start date | Sep 1, 1999 |
| Primary completion | Jan 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 23, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: